Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Bertrand

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
MLO: Medical Laboratory Observer|June 8, 1988
Launching a hospital-based 2 + 2 MT programK C Bertrand, R T O'Kell
Neuropathology and Applied Neurobiology|February 29, 2020
Invited Review: The role and contribution of transcriptional enhancers in brain cancerA Arabzade, A J Stuckert, K C Bertrand, et al.
Journal of Neuro-Oncology|September 23, 2020
Weighing ependymoma as an epigenetic diseaseA Stuckert, K C Bertrand, P Wang, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 5, 2013
Hippocampal-sparing radiotherapy: the new standard of care for World Health Organization grade II and III gliomas?M B Pinkham, K C Bertrand, S Olson, et al.
Nature Cell Biology|August 27, 2025
Synthetic ZFTA fusions pinpoint disordered protein domain acquisition as a mechanism of brain tumorigenesisA Arabzade, H K Shirnekhi, S Varadharajan, et al.
Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
MLO: Medical Laboratory Observer|June 8, 1988
Launching a hospital-based 2 + 2 MT programK C Bertrand, R T O'Kell
Neuropathology and Applied Neurobiology|February 29, 2020
Invited Review: The role and contribution of transcriptional enhancers in brain cancerA Arabzade, A J Stuckert, K C Bertrand, et al.
Journal of Neuro-Oncology|September 23, 2020
Weighing ependymoma as an epigenetic diseaseA Stuckert, K C Bertrand, P Wang, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 5, 2013
Hippocampal-sparing radiotherapy: the new standard of care for World Health Organization grade II and III gliomas?M B Pinkham, K C Bertrand, S Olson, et al.
Nature Cell Biology|August 27, 2025
Synthetic ZFTA fusions pinpoint disordered protein domain acquisition as a mechanism of brain tumorigenesisA Arabzade, H K Shirnekhi, S Varadharajan, et al.
Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.
Pageof 1